Hilltop Bio is proud to announce Mid Atlantic Bio Angels (MABA) as its newest investor. MABA is an angel investor group focused exclusively on new and emerging life science companies by invitation only. MABA’s members include practicing physicians, executives within small and large life science companies, and corporate members from the industry.
MABA Co-Founder Yaniv Sneor stated, “We are pleased to announce Hilltop as MABA’s most recent investment. This is MABA’s first opportunity to engage with a veterinary biotech company whom we believe will have a positive impact on improving the standard of care for treatment of inflammatory diseases in the veterinary space.”
Read MABA’s full press release.
